Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOIRON Interim / Quarterly Report 2014

Jul 15, 2014

1161_iss_2014-07-15_ed2b8036-2b29-45ec-874b-dc90483f3a01.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

2014 HALF-YEAR ACTIVITY

(Unaudited data)

CUMULATIVE ACTIVITY AS OF THE END OF JUNE 2014

In thousands of euros 2013 2014 Variation at
current exchange
rates
Variation at
constant
exchange rates
France 159,597 157,018 - 1.6% - 1.6%
International : 116,187 104,598 - 10.0% - 7.0%
Incl. Europe (excluding France) 83,381 73,537 - 11.8% - 9.6%
Incl. North America 25,579 23,287 - 9.0% - 3.7%
Incl. Other countries 7,227 7,774 + 7.6% + 11.2%
Group Total 275,784 261,616 - 5.1% - 3.9%
In thousands of euros 2013 2014 Variation at
current exchange
rates
Variation at
constant
exchange rates
Non-proprietary Homeopathic Medicines 152,097 150,991 - 0.7% - 0.4%
OTC Specialties 123,466 110,254 - 10.7% - 8.3%
Other 221 371 + 67.9% + 59.7%
Group Total 275,784 261,616 - 5.1% - 3.9%

ACTIVITY IN THE QUARTER (variation at current rate)

In thousands of euros st Quarter
1
nd Quarter
2
2013 2014 Var. 2013 2014 Var.
France 84,270 82,749 -1.8% 75,327 74,269 -1.4%
International : 73,751 57,460 -22.1% 42,436 47,138 + 11.1%
Incl. Europe (excluding France) 54,334 39,967 -26.4% 29,047 33,570 + 15.6%
Incl. North America 15,562 12,662 -18.6% 10,017 10,625 + 6.1%
Incl. Other countries 3,855 4,831 + 25.3% 3,372 2,943 -12.7%
Group Total 158,021 140,209 - 11.3% 117,763 121,407 +3.1%
In thousands of euros st Quarter
1
nd Quarter
2
2013 2014 Var. 2013 2014 Var.
Non-proprietary Homeopathic Medicines 79,062 77,919 -1.4% 73,035 73,072 + 0.1%
OTC Specialties 78,866 62,196 -21.1% 44,600 48,058 + 7.8%
Other 93 94 + 1.1% 128 277 + 116.4%
Group Total 158,021 140,209 - 11.3% 117,763 121,407 +3.1%

2014 SECOND QUARTER HIGHLIGHTS

Sales in the second quarter of 2014 increased by 3.1% compared to the second quarter of 2013.

Income in the first half of 2014 should be lower than the first half of 2013 which benefited from exceptionally high business volume.

At June 30, 2014, the group's cash amounted to approximately 140 million euros.

Given the uncertainty of seasonal illnesses in the second half-year period, the group confirms its cautiousness regarding 2014.

Our next update:

August 29, 2014: at market close, publication of 2014 half-year results. Person responsible for financial information: Christian Boiron Contact for financial information: Véronique Bouscayrol Investor relations: +33 (0) 4.78.45.63.43 - e-mail : [email protected] ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA The group's financial information is online at: www.boiron.com